To evaluate the effect of sclerostin antibody on the progression of cardiovascular events in OI, Col1a2+/G610C.ApoE-/- mouse model (OI.ApoE-/-) was constructed (Figure S1A). The gene discussed is APOE; the disease is osteogenesis imperfecta.